-
A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen in Patients With Dravet Syndrome
-
A Study to Evaluate the Efficacy, Safety, and Tolerability of Brivaracetam as Monotherapy in Patients 2 to 25 Years of Age With Childhood Absence Epilepsy or Juvenile Absence Epilepsy (EXPAND)
-
A Study to Test the Long-term Safety and Tolerability of Brivaracetam in Study Participants With Childhood Absence Epilepsy or Juvenile Absence Epilepsy
-
Blood Brain Barrier (BBB) Disruption Using Exablate Focused Ultrasound With Doxorubicin for Treatment of Pediatric Diffuse Intrinsic Pontine Gliomas (DIPG)
-
Efficacy and Safety of Erenumab in Pediatric Participants With Episodic Migraine (OASIS(EM))
-
Focal Cerebral Arteriopathy Steroid Trial (FOCAS)
-
Humanitarian Device Exemption (Dystonia IRB)
-
Phase 3 Efficacy and Safety Study of GTX-102 in Pediatric Subjects with AS (Aspire)
-
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
-
Study to Assess the Efficacy, Safety, and Tolerability of Valbenazine for the Treatment of Dyskinesia Due to Cerebral Palsy
